| 繁體中文 | English
首页 | 学术期刊 | 学位论文 | 学术会议 | 中外专利 | 中外标准 | 科技成果 | 新方志 | 法律法规 | 专题
浏览历史
首页 > NSTL期刊 > 其它
Diabetic neuropathy represents a major health problem worldwide. Along with measures for glycemic control, most patients require pharmacological treatment for painful symptoms. The efficacy of many agents has been confirmed in randomized controlled trials. We administered a questionnaire to the M.D.-qualified general physicians practicing in the locality, inquiring about their prescribing preferences among the drug options that were provided, to treat painful diabetic neuropathy (PDN). Respondents could add to their choice the names of drugs they prescribed but were missing in the questionnaire. This cross-sectional survey, which was approved by the institutional ethics committee, was conducted after obtaining verbal informed consent of the participants. Eighty-nine (out of 90) anonymous questionnaires were returned, and the prescribing preferences were tabulated [Table 1].